Pulmonary Hypertension News Forums Forums PH Care and Treatment Treatments and Therapies phaware, Antidote Technologies Recruiting Patients for Trials

  • phaware, Antidote Technologies Recruiting Patients for Trials

    Posted by pulmonary-hypertension-news-moderator on August 31, 2018 at 7:53 am

    Antidote Technologies, a digital health company, and phaware global association, an organization advocating for pulmonary hypertension (PH) awareness, will join forces to create a new recruitment system for pharmaceutical companies and contract research organizations (CROs) to enroll patients with chronic lung diseases in their clinical trials.

    The partnership will bring together phaware’s proven patient engagement model and Antidote’s expertise on recruitment for clinical trials, to improve the recruitment efficiency of patients with PH and related diseases. Click here to read more about this story.

    What are your thoughts on this news?

    replied 5 years, 7 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.